U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734675) titled 'Sociocognitive Intervention and Rehabilitation Program in Multiple Sclerosis' on July 14.
Brief Summary: Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system, involving inflammation, demyelination, and neurodegeneration. It is the most common non-traumatic disabling disease affecting young adults. MS is characterized by its heterogeneity and unpredictable course, which make both evaluation and treatment complex. Patients may present with motor, sensory, cognitive, and neuropsychiatric symptoms, all of which have a significant impact on quality of life.
With regard to cognition, the impact of cogniti...